USD 1.72
(-1.15%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2.77 Million USD | 19.42% |
2022 | 2.32 Million USD | 21.77% |
2021 | 1.91 Million USD | -17.77% |
2020 | 2.32 Million USD | 94.97% |
2019 | 1.19 Million USD | -34.03% |
2018 | 1.8 Million USD | -5.84% |
2017 | 1.91 Million USD | 29.75% |
2016 | 1.47 Million USD | 3.64% |
2015 | 1.42 Million USD | 65.93% |
2014 | 860 Thousand USD | 402.92% |
2013 | 171 Thousand USD | 39.03% |
2012 | 122.99 Thousand USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 3.04 Million USD | 9.54% |
2024 Q2 | 3.75 Million USD | 23.32% |
2023 Q3 | 2.86 Million USD | 7.26% |
2023 Q1 | 2.03 Million USD | -12.76% |
2023 Q2 | 2.67 Million USD | 31.72% |
2023 FY | 2.77 Million USD | 19.42% |
2023 Q4 | 2.77 Million USD | -3.1% |
2022 Q4 | 2.32 Million USD | -7.95% |
2022 Q2 | 2.08 Million USD | 259.09% |
2022 Q3 | 2.52 Million USD | 21.01% |
2022 FY | 2.32 Million USD | 21.77% |
2022 Q1 | 581.75 Thousand USD | -69.56% |
2021 Q2 | 2.11 Million USD | 343.54% |
2021 Q4 | 1.91 Million USD | 300.0% |
2021 FY | 1.91 Million USD | -17.77% |
2021 Q1 | 477.75 Thousand USD | -79.44% |
2021 Q3 | 477.75 Thousand USD | -77.45% |
2020 FY | 2.32 Million USD | 94.97% |
2020 Q1 | 1.73 Million USD | 45.55% |
2020 Q2 | 1.73 Million USD | 0.0% |
2020 Q3 | 2.32 Million USD | 33.95% |
2020 Q4 | 2.32 Million USD | 0.0% |
2019 Q1 | 1.17 Million USD | -35.09% |
2019 FY | 1.19 Million USD | -34.03% |
2019 Q2 | 1.17 Million USD | 0.0% |
2019 Q4 | 1.19 Million USD | 0.0% |
2019 Q3 | 1.19 Million USD | 1.62% |
2018 Q2 | 1.41 Million USD | 0.0% |
2018 Q3 | 1.8 Million USD | 28.07% |
2018 Q4 | 1.8 Million USD | 0.0% |
2018 FY | 1.8 Million USD | -5.84% |
2018 Q1 | 1.41 Million USD | -26.47% |
2017 Q4 | 1.91 Million USD | 0.0% |
2017 Q3 | 1.91 Million USD | 38.26% |
2017 Q2 | 1.38 Million USD | 0.0% |
2017 Q1 | 1.38 Million USD | -6.15% |
2017 FY | 1.91 Million USD | 29.75% |
2016 Q3 | 1.47 Million USD | 16.09% |
2016 Q1 | 1.27 Million USD | -10.72% |
2016 Q4 | 1.47 Million USD | 0.0% |
2016 FY | 1.47 Million USD | 3.64% |
2016 Q2 | 1.27 Million USD | 0.0% |
2015 Q1 | 1.79 Million USD | 108.26% |
2015 Q3 | 1.42 Million USD | -20.32% |
2015 FY | 1.42 Million USD | 65.93% |
2015 Q4 | 1.42 Million USD | 0.0% |
2015 Q2 | 1.79 Million USD | 0.0% |
2014 Q3 | 860 Thousand USD | 2.87% |
2014 Q2 | 836 Thousand USD | 0.0% |
2014 Q1 | 836 Thousand USD | 388.89% |
2014 Q4 | 860 Thousand USD | 0.0% |
2014 FY | 860 Thousand USD | 402.92% |
2013 FY | 171 Thousand USD | 39.03% |
2013 Q4 | 171 Thousand USD | 0.0% |
2013 Q3 | 171 Thousand USD | 24.0% |
2013 Q2 | 137.9 Thousand USD | 1.54% |
2013 Q1 | 135.81 Thousand USD | 10.43% |
2012 Q1 | 30.74 Thousand USD | 0.0% |
2012 FY | 122.99 Thousand USD | 0.0% |
2012 Q4 | 122.99 Thousand USD | -0.01% |
2012 Q3 | 123 Thousand USD | 0.0% |
2012 Q2 | - USD | -100.0% |
2011 Q4 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q3 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
2006 FY | - USD | 0.0% |
2006 Q4 | - USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q4 | - USD | 0.0% |
2005 Q3 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aclaris Therapeutics, Inc. | - USD | -Infinity% |
Biodesix, Inc. | 1.4 Million USD | -98.5% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -14934.625% |
Castle Biosciences, Inc. | 7.94 Million USD | 65.009% |
DarioHealth Corp. | 5.06 Million USD | 45.101% |
Exact Sciences Corporation | 127.47 Million USD | 97.82% |
IDEXX Laboratories, Inc. | 380.28 Million USD | 99.269% |
Illumina, Inc. | 587 Million USD | 99.527% |
Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -257.411% |
iSpecimen Inc. | - USD | -Infinity% |
Standard BioTools Inc. | 20.53 Million USD | 86.466% |
23andMe Holding Co. | 12.46 Million USD | 77.706% |
Medpace Holdings, Inc. | 1.00 USD | -277899900.0% |
NeoGenomics, Inc. | 24.15 Million USD | 88.496% |
Inotiv, Inc. | 56.1 Million USD | 95.047% |
Psychemedics Corporation | 1.00 USD | -277899900.0% |
Prenetics Global Limited | 3.12 Million USD | 11.123% |
Precipio, Inc. | 384 Thousand USD | -623.698% |
RadNet, Inc. | 1.00 USD | -277899900.0% |
Sotera Health Company | 51.98 Million USD | 94.654% |
Star Equity Holdings, Inc. | 3.42 Million USD | 18.743% |
Exagen Inc. | 2.87 Million USD | 3.204% |
Natera, Inc. | 40.75 Million USD | 93.182% |
Aspira Women's Health Inc. | 227 Thousand USD | -1124.229% |
Neogen Corporation | 189.26 Million USD | 98.532% |
Myriad Genetics, Inc. | 20.1 Million USD | 86.174% |
ICON Public Limited Company | 1.00 USD | -277899900.0% |
Bionano Genomics, Inc. | 22.89 Million USD | 87.861% |
CareDx, Inc | 19.47 Million USD | 85.727% |
Check-Cap Ltd. | - USD | -Infinity% |
Twist Bioscience Corporation | 32.06 Million USD | 91.333% |
Guardant Health, Inc. | 61.94 Million USD | 95.514% |
BioNexus Gene Lab Corp. | 1.13 Million USD | -144.25% |
Fulgent Genetics, Inc. | 5.82 Million USD | 52.308% |
Sera Prognostics, Inc. | - USD | -Infinity% |
OPKO Health, Inc. | 65.69 Million USD | 95.77% |
Personalis, Inc. | 5.66 Million USD | 50.91% |
Applied DNA Sciences, Inc. | 330.02 Thousand USD | -742.052% |
Star Equity Holdings, Inc. | 3.42 Million USD | 18.743% |
Prenetics Global Limited | 3.12 Million USD | 11.123% |
ENDRA Life Sciences Inc. | 2.62 Million USD | -5.953% |
Mainz Biomed B.V. | 613.63 Thousand USD | -352.873% |
Trinity Biotech plc | 19.93 Million USD | 86.058% |
Neuronetics, Inc. | 8.09 Million USD | 65.662% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -14934.625% |